Skip to main content
BOSTON SCIENTIFIC CORP logo

BOSTON SCIENTIFIC CORP — Investor Relations & Filings

Ticker · BSX ISIN · US1011371077 LEI · Y6ZDD9FP4P8JSSJMW954 US Manufacturing
Open in API
Filings indexed 3,157 across all filing types
Latest filing 2022-04-27 Regulatory Filings
Country US United States of America
Listing US BSX

About BOSTON SCIENTIFIC CORP

https://www.bostonscientific.com/en-US/…

Boston Scientific Corporation is a global medical technology company that develops, manufactures, and commercializes a broad range of high-performance medical devices. The company's products are used in various minimally invasive, interventional medical specialties, including cardiology, endoscopy, neuromodulation, urology, and pelvic health. Focused on transforming lives through innovative solutions, Boston Scientific is dedicated to improving the health of patients worldwide by addressing complex healthcare challenges and enhancing clinical outcomes.

Recent filings

Filing Released Lang Actions
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The text specifically mentions that the company issued a press release announcing financial results for the first quarter ended March 31, 2022, and that the press release is furnished as an exhibit. The document itself does not contain detailed financial statements or substantive financial data but rather references the press release. The length of the document is 3838 characters, which is relatively short and consistent with an announcement rather than a full report. According to the rules, such a document that announces or furnishes a press release of financial results without containing the full financial data should be classified as a Regulatory Filing (RNS), as it does not meet the criteria for an Earnings Release (ER) or Interim Report (IR) itself. Therefore, the appropriate classification is Regulatory Filings (RNS).
2022-04-27 English
Director's Dealing 2022
Director's Dealing
2022-04-21 English
Director's Dealing 2022
Director's Dealing
2022-04-20 English
Director's Dealing 2022
Director's Dealing
2022-04-14 English
8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is used for current reports on significant events. The content specifically details the departure and appointment of senior executives and changes in their roles within the company. There is no financial data or report attached, nor is it an announcement of a report publication. The key focus is on management changes, which aligns with the category for Board/Management Information (MANG). The document length is under 5,000 characters and is a direct report of management changes, not a report publication or certification. Therefore, the appropriate classification is MANG with high confidence.
2022-04-05 English
Director's Dealing 2022
Director's Dealing
2022-04-04 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.